Skip to main content
OpenTrials
Completed

NCT Number: NCT01418482

Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns

The investigation is designed as an open, non-controlled, post-marketing investigation. Subjects with at least one second degree burn less than 9.5x15 cm in size at 1-3 sites will be included. The subject is allowed to have more than one burn on the body but only one should be included in the investigation. Each subject will be followed/assessed according to normal hospital routine 1-3 times per week for a maximum of 3 weeks or until desired treatment effect is obtained if that occurs earlier. All dressing changes will be done according to clinical routine and will follow the IFU (instruction for use). All dressing changes will be registered in a dressing log. Additional compression bandaging, gauze wrap, or such are allowed and should be reported as well

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Burns Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Briva/Hpk, Linköping, Sweden

Loading trial locations.

About this study

At baseline, subject characteristics will be registered together with subject status of health and status of the burn, and current treatment of the burn.

At each visit the following variables will be collected where applicable:

  • Investigator's/Nurse evaluation of
  • Overall experience of the dressing
  • Ability of dressing to stay in place (not at baseline)
  • Conformability of the dressing
  • Handling at application
  • Ease of removal of the dressing (not at baseline)
  • Subject evaluation of
  • Overall experience of the dressing
  • Comfort of the dressing
  • Conformability of the dressing
  • Pain before, during and after removal of dressing according to VAS
  • Status of skin
  • Burn status: width x length, exudate details and signs of inflammation/infection

In addition the following variables should be evaluated at each visit:

  • Concomitant medication/treatment
  • Adverse Event/Adverse Device Effect (AE/ADE)
  • Serious Adverse Event/Serious Adverse Device Effect (sAE/sADE)

Photos will be taken before Mepilex Border Ag is removed, after removal, before cleansing, and after cleansing. All photos must include a sticker marker with subject code, visit number and date, and an indication of whether pre-/post removal, pre-/post cleansing. The stick marker also contains a ruler. Detailed instructions on how to take the photos is given in Appendix 14.2

At each visit the subject will give the assessment concerning the comfort and stay-on-ability of the dressing. The investigator will also give an assessment at each visit concerning handling, conformability and ability of dressing to stay in place.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject with a small partial thickness burn (< 9.5x15 cm) where an antimicrobial action is indicated as judged by the investigator*
  • Male or female, 18 years and above, both in- and out-patient subjects
  • Signed Informed Consent Form

Exclusion criteria

  • Wound size equal to or above 9.5x15cm for the selected burn for the investigation
  • Pregnant and/or breastfeeding women
  • Subject not expected to follow the investigation procedures or applicable for investigation according to the judgment of the investigator
  • Subjects with known sensitivity to silver or any other contents of the dressing
  • Subjects previously included in this investigation
  • Subjects included in other ongoing clinical investigation at present or during the past 30 days

Treatment and study plan

Mepilex Border Ag

Device

a silver dressing

Primary outcomes

  1. Evaluate the Experience of Using Mepilex Border Ag ( a Silver Dressing) in Normal Clinical Practice

    Time frame: 3 weeks

    burns healed

Secondary outcomes

  1. Evaluate the Comfort

    Time frame: 3 weeks

    Comfort level and overall experience were each assessed using a scale that ranged from very poor to very good.

  2. Pain

    Time frame: 3 weeks

    To evaluate pain during dressing removal at visit 4,(after one week) with John Hopkins pain scale. Measured 0=no pain, 100= worst pain, scale from 0-100 mm

Sponsors and collaborators

Lead sponsor

Molnlycke Health Care AB

Industry

Registry information

Official study title

An Open Non-controlled Post-marketing Investigation Evaluating the Experience of Using a Self- Adherent Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Aug 17, 2011
Registry last updated
Jun 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.